Ftse Mib
34.208,99
-0,25%
DAX
18.046,73
-0,47%
S&P 500
5.116,17
0,32%
NASDAQ Composite
15.983,08
0,35%
Bitcoin
61.908,19
-3,02%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Arrowhead Pharmaceuticals Inc (ARWR) Arrowhead Pharmaceuticals Inc (ARWR) Notizie

Arrowhead Pharmaceuticals Inc

ARWR
23,13
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:28:06
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/4/202415:00GLOBETurnstone Biologics Appoints William Waddill to its Board of..
08/3/202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:30EDGAR2Form 144 - Report of proposed sale of securities
27/2/202423:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/2/202422:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/2/202422:07EDGAR2Form 8-K - Current report
02/2/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:57EDGAR2Form 144 - Report of proposed sale of securities
26/1/202423:28EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/1/202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:22EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
17/1/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202422:16EDGAR2Form 144 - Report of proposed sale of securities
11/1/202422:48EDGAR2Form 144 - Report of proposed sale of securities
11/1/202422:38EDGAR2Form 144 - Report of proposed sale of securities
11/1/202422:22EDGAR2Form 144 - Report of proposed sale of securities
11/1/202422:05EDGAR2Form 144 - Report of proposed sale of securities
08/1/202423:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202401:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202423:33EDGAR2Form 144 - Report of proposed sale of securities
05/1/202423:14EDGAR2Form 144 - Report of proposed sale of securities
05/1/202422:58EDGAR2Form 144 - Report of proposed sale of securities
05/1/202422:39EDGAR2Form 144 - Report of proposed sale of securities
05/1/202422:21EDGAR2Form 144 - Report of proposed sale of securities
05/1/202422:08EDGAR2Form 144 - Report of proposed sale of securities
04/1/202423:27EDGAR2Form 8-K - Current report
04/1/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/1/202419:49EDGAR2Form 144 - Report of proposed sale of securities
04/1/202419:25EDGAR2Form 144 - Report of proposed sale of securities
04/1/202419:06EDGAR2Form 144 - Report of proposed sale of securities
04/1/202418:24EDGAR2Form 144 - Report of proposed sale of securities
02/1/202422:44EDGAR2Form 144 - Report of proposed sale of securities
22/12/202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202322:34EDGAR2Form 144 - Report of proposed sale of securities
19/12/202322:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202321:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202321:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202321:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202321:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202321:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202323:16EDGAR2Form 8-K - Current report
29/11/202322:10EDGAR2Form 8-K - Current report
29/11/202322:09EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
Apertura: Min: Max:
Chiusura: 23,13

La tua Cronologia

NASDAQ
ARWR
Arrowhead Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network